19 hours AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates Zacks
AngioDynamics (ANGO) delivered earnings and revenue surprises of 63.64% and 2.36%, respectively, for the quarter ended November 2024. Do the numbers hold clues to what lies ahead for the stock?
X